Fengmin Lu

1.0k total citations
20 papers, 675 citations indexed

About

Fengmin Lu is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Fengmin Lu has authored 20 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 6 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Fengmin Lu's work include Hepatitis B Virus Studies (7 papers), Viral gastroenteritis research and epidemiology (5 papers) and Hepatitis C virus research (5 papers). Fengmin Lu is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Viral gastroenteritis research and epidemiology (5 papers) and Hepatitis C virus research (5 papers). Fengmin Lu collaborates with scholars based in China, United States and Switzerland. Fengmin Lu's co-authors include Bernadette Kálmán, Mary Selak, Carlos Lorenzana, Sidney Croul, John O’Connor, Hui Zhuang, Xiangmei Chen, Qunying Mao, Junzhi Wang and Zhenglun Liang and has published in prestigious journals such as Gastroenterology, Carbohydrate Polymers and Journal of Hepatology.

In The Last Decade

Fengmin Lu

18 papers receiving 670 citations

Peers

Fengmin Lu
Wu Liu China
Yun Feng China
Lindsay Webb United States
Ming Shao China
Kurt Q. Lu United States
Fengmin Lu
Citations per year, relative to Fengmin Lu Fengmin Lu (= 1×) peers Martina Blaschke

Countries citing papers authored by Fengmin Lu

Since Specialization
Citations

This map shows the geographic impact of Fengmin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengmin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengmin Lu more than expected).

Fields of papers citing papers by Fengmin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengmin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengmin Lu. The network helps show where Fengmin Lu may publish in the future.

Co-authorship network of co-authors of Fengmin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengmin Lu. A scholar is included among the top collaborators of Fengmin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengmin Lu. Fengmin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fengjie, Yan‐Peng Xu, Zhenzhi Han, et al.. (2025). The Changed Endemic Pattern of Respiratory Syncytial Virus Infections in Pediatric Patients With the Relaxation of NPIs in Beijing, China, 2022−2023. Journal of Medical Virology. 97(4). e70348–e70348.
2.
Liu, Xin, et al.. (2025). Host Factor SRSF7 Promotes HBV Replication Through Binding to and Stabilising Viral pgRNA. Journal of Viral Hepatitis. 32(6). e70024–e70024.
3.
Sun, Yu, Siyuan Huang, Runan Zhu, et al.. (2024). A Scoring System to Predict Severe Acute Lower Respiratory Infection in Children Caused by Respiratory Syncytial Virus. Microorganisms. 12(7). 1411–1411. 2 indexed citations
4.
Liu, Tianxu, Xinyue Yang, Tianyu Tang, et al.. (2024). An Immunocompetent Mongolian Gerbil Model for Hepatitis E Virus Genotype 1 Infection. Gastroenterology. 167(4). 750–763.e10. 20 indexed citations
5.
Zhao, Jing, Dan‐Dan Bian, Hao Liao, et al.. (2023). Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients. Frontiers in Cellular and Infection Microbiology. 13. 1083912–1083912. 8 indexed citations
6.
Liu, Feng, Ruifeng Yang, Dongbo Chen, et al.. (2021). Prevention and control measures significantly curbed the SARS-CoV-2 and influenza epidemics in China. Journal of Virus Eradication. 7(2). 100040–100040. 7 indexed citations
7.
Wang, Jie, Ran Chen, Qiang Xu, et al.. (2018). RFX1 participates in doxorubicin‐induced hepatitis B virus reactivation. Cancer Medicine. 7(5). 2021–2033. 14 indexed citations
8.
Wang, Jie, Qiuju Sheng, Yang Ding, et al.. (2017). HBV RNA virion-like particles produced under nucleos(t)ide analogues treatment are mainly replication-deficient. Journal of Hepatology. 68(4). 847–849. 29 indexed citations
9.
Chen, Xiangmei, Ling Zhang, Sujun Zheng, et al.. (2015). Hepatitis B Virus X Protein Stabilizes Cyclin D1 and Increases Cyclin D1 Nuclear Accumulation through ERK-Mediated Inactivation of GSK-3β. Cancer Prevention Research. 8(5). 455–463. 18 indexed citations
10.
Wang, Jie, Fengmin Lu, & Hui Zhuang. (2013). [The analysis on the epidemic trend of viral hepatitis in China during recent 10 years (2002-2011)].. PubMed. 21(8). 561–4. 3 indexed citations
11.
Nie, Jingjing, Jie Li, Jie Wang, et al.. (2012). A type-specific nested PCR assay established and applied for investigation of HBV genotype and subgenotype in Chinese patients with chronic HBV infection. Virology Journal. 9(1). 121–121. 14 indexed citations
12.
Gao, Fan, Yiping Wang, Qunying Mao, et al.. (2012). Enterovirus 71 viral capsid protein linear epitopes: Identification and characterization. Virology Journal. 9(1). 26–26. 37 indexed citations
13.
Chen, Xiangmei, Ling Zhang, Ting Zhang, et al.. (2012). Methylation‐mediated repression of microRNA 129‐2 enhances oncogenic SOX4 expression in HCC. Liver International. 33(3). 476–486. 59 indexed citations
14.
Mao, Qunying, Nan Li, Yu Xiang, et al.. (2011). Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71. Archives of Virology. 157(1). 37–41. 41 indexed citations
15.
Mao, Qunying, Xueyan Liao, Yu Xiang, et al.. (2010). Dynamic change of mother-source neutralizing antibodies against enterovirus 71 and coxsackievirus A16 in infants. Chinese Medical Journal. 123(13). 1679–1684. 21 indexed citations
16.
Xu, Gaolian, Qimin You, Hongying Wang, et al.. (2010). Application of PCR‐LDR‐nucleic acid detection strip in detection of YMDD mutation in hepatitis B patients treated with lamivudine. Journal of Medical Virology. 82(7). 1143–1149. 13 indexed citations
17.
Zhou, Yingshan, Guiping Ma, Suqing Shi, et al.. (2009). A water-soluble photocrosslinkable chitosan derivative prepared by Michael-addition reaction as a precursor for injectable hydrogel. Carbohydrate Polymers. 79(3). 507–512. 55 indexed citations
18.
DeScipio, Cheryl, Lori Schneider, Terri L. Young, et al.. (2005). Subtelomeric deletions of chromosome 6p: Molecular and cytogenetic characterization of three new cases with phenotypic overlap with Ritscher?Schinzel (3C) syndrome. American Journal of Medical Genetics Part A. 134A(1). 3–11. 54 indexed citations
19.
Lu, Fengmin, Mary Selak, John O’Connor, et al.. (2000). Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. Journal of the Neurological Sciences. 177(2). 95–103. 268 indexed citations
20.
Lu, Fengmin & Bernadette Kálmán. (1999). Autoreactive IgG to intracellular proteins in sera of MS patients. Journal of Neuroimmunology. 99(1). 72–81. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026